Our findings demonstrate robust evidence supporting the role of serum cystatin C as an independent predictor of stroke morbidity after full adjustment for comorbidities (Model 3 OR = 1.27, 95% CI: 1.02–1.58), in line with previous observational and genetic studies. This evidence concerns the gene CST3 and Stroke.